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 ABSTRACT 47 
 48 
We have characterized the native voltage-dependent K+ (Kv) current in rabbit urethral smooth 49 
muscle cells (RUSMC) and compared its pharmacological and biophysical properties with 50 
Kv2.1 and Kv2.2 channels cloned from the rabbit urethra and stably expressed in HEK 293 51 
cells (HEKKv2.1 and HEKKv2.2). RUSMC were perfused with Hanks' solution at 37°C and 52 
studied using the patch clamp technique with K+-rich pipette solutions. Cells were bathed in 53 
100 nM penitrem A (Pen A) to block large conductance Ca2+-activated K+ (BK) currents and 54 
depolarized to +40 mV for 500 ms to evoke Kv currents. These were unaffected by 55 
margatoxin, κ-dendrotoxin or α-dendrotoxin (100 nM, n=3-5), but were blocked by 56 
stromatoxin-1 (ScTx, IC50~130 nM), consistent with the idea that the currents were carried 57 
through Kv2 channels. RNA was detected for Kv2.1 Kv2.2 and the silent subunit Kv9.3 in 58 
urethral smooth muscle. Immunocytochemistry showed membrane staining for both Kv2 59 
subtypes and Kv9.3 in isolated RUSMC. HEKKv2.1 and HEKKv2.2 currents were blocked in a 60 
concentration dependent manner by ScTx with estimated IC50 values of ~150 nM (Kv2.1, 61 
n=5) and 70 nM (Kv2.2, n=6). The mean V1/2 of inactivation of the USMC Kv current was –62 
56±3 mV (n=9). This was similar to the HEKKv2.1 current (–55 ± 3 mV, n=13) but 63 
significantly different from the HEKKv2.2 currents (-30 ± 3 mV, n=11). Action potentials (AP) 64 
evoked from RUSMC studied under current clamp mode were unaffected by ScTx.  However 65 
when ScTx was applied in the presence of Pen A, the AP duration was significantly 66 
prolonged. Similarly, ScTx increased the amplitude of spontaneous contractions threefold, 67 
but only after Pen A application.  68 
These data suggest that Kv2.1 channels contribute significantly to the Kv current in RUSMC. 69 
 70 
 71 
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INTRODUCTION  73 
 74 
The urethra plays an important role in the maintenance of urinary continence by generating 75 
sufficient force to prevent urine outflow from the bladder. The spontaneous activity in the 76 
urethra is thought to be initiated and modulated by specialised pacemaking cells, which 77 
control the bulk smooth muscle (33). Although a number of studies have characterised the 78 
main inward currents in urethral smooth muscle and assessed their role in urethral tone (6, 9, 79 
18), little is known about the voltage gated K+ (Kv) currents in these cells. The majority of 80 
work on urethral K+ currents has focused on examining the role of KATP channels in isolated 81 
pig myocytes (34, 35, 36). The contribution of other K+ channels to the electrical activity in 82 
the urethra is poorly understood and few studies have focused on examining which Kv 83 
subtypes are present (5). Hollywood et al. (2000) unmasked an iberiotoxin- and Pen A-84 
insensitive Kv current, which was TEA-sensitive and contributed to the repolarisation phase 85 
of evoked action potentials. However, the molecular identity of the Kv channels underlying 86 
the Kv current in urethra remain undetermined. 87 
The molecular identity of Kv channels in the bladder (7, 24, 37) has been examined in more 88 
detail and it has been demonstrated that Kv2 expression is significantly higher than Kv1 in the 89 
rat bladder (24). Similarly, Thornloe & Nelson (2003) found that the delayed rectifier 90 
currents in murine urinary bladder cells were likely to be carried through Kv2.1 channels. It is 91 
likely that these channels help regulate contractions in the bladder since, blockade of Kv2 92 
channels with stromatoxin-1 (ScTx) enhances both myogenic and neurogenic contractions in 93 
the rat bladder (7).  94 
Given that Kv2 channels appear to play an important role in bladder smooth muscle, we have 95 
examined if they also contribute to the delayed rectifier in urethral smooth muscle. In this 96 
paper, the molecular identity and cellular expression of the Kv current present in RUSMCs is 97 
examined and the biophysical, pharmacological and functional properties of the Kv current 98 
are investigated.  The results demonstrate that isolated RUSMC are immunopositive for Kv2 99 
channels and a ScTx sensitive Kv2 channel is likely to carry the Kv current in freshly 100 
dispersed rabbit urethral myocytes. Furthermore a comparison of the native current with 101 
Kv2.1 and Kv2.2 cloned from the rabbit urethra and stably expressed in HEK 293 cells 102 
suggests that the native current shares a number of features consistent with it being Kv2.1. 103 
These data suggest that although Kv2 channels can modify electrical activity and myogenic 104 
contractions, they only play a significant role when BK currents are inhibited. 105 
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Materials and Methods 107 
All procedures were carried out in accordance with current EU legislation and with the 108 
approval of Dundalk Institute of Technology Animal Care and Use Committee. Male and 109 
female New Zealand white rabbits (16-20 weeks old) were humanely killed with a lethal 110 
injection of pentobarbitone (i.v.) 111 
 112 
Cell Isolation 113 
The most proximal 1.5 cm of the urethra was removed and placed in Krebs solution. Strips of 114 
proximal urethra, 0.5 cm in width were cut into 1 mm3 pieces and stored in Hanks Ca2+ free 115 
solution for 30 min before being incubated in dispersal medium containing (per 5mls of Ca2+-116 
free Hanks solution (see solutions)): 15mg collagenase (Sigma type 1A), 0.5mg protease 117 
(Sigma type XXIV), 5mg bovine serum albumin (Sigma) and 15mg trypsin inhibitor (Sigma) 118 
for 10-15 mins at 37˚C. Tissue was then transferred to Ca2+-free Hanks solution and stirred 119 
for a further 15-30 min to release single smooth muscle cells. These cells were plated in petri 120 
dishes containing 100 μM Ca2+ Hank’s solution and stored at 4˚C for use within 8 hours.  121 
 122 
Patch Clamp Recordings 123 
Currents from RUSMC were recorded with the perforated patch configuration of the whole 124 
cell patch clamp technique (28). The cell membrane was perforated using the antibiotic 125 
amphotericin B (600µg/ml). Patch pipettes were initially front-filled by dipping into pipette 126 
solution and then back filled with the amphotericin B containing solution. For experiments 127 
on HEK293 cells, currents were recorded using the ruptured patch configuration of the patch 128 
clamp technique (13). Pipettes were pulled from borosilicate glass capillary tubing (1.5mm 129 
outer diameter, 1.17mm inner diameter; Clark Medical Instruments) to a tip of diameter 130 
approximately 1-1.5µm and resistance of 2-4MΩ.  131 
Series resistance and capacitative currents were usually compensated by up to 80% in this 132 
study. Voltage clamp commands were delivered via an Axopatch 1D patch clamp amplifier 133 
(Axon Instruments) connected to a Digidata 1322A AD/DA converter (Axon Instruments) 134 
interfaced to a computer running pClamp software (Axon Instruments). 135 
 136 
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Solutions 137 
The composition of the solutions used was as follows (in mM): Hanks solution: 129.8 Na+, 138 
5.8 K+, 135 Cl-, 4.17 HCO3- 0.34 HPO42-, 0.44 H2PO4
-
, 1.8 Ca2+, 0.9 Mg2+, 0.4 SO42-, 10 139 
glucose, 2.9 sucrose and 10 HEPES, pH adjusted to 7.4 with NaOH. Ca2+ free Hanks 140 
perfusate solution: 129.8 Na
+
, 5.8 K
+
, 135 Cl-, 4.17 HCO3-, 0.34 HPO42-, 0.44 H2PO4-, 2.7 141 
Mg2+, 0.4 SO42-, 10 glucose, 2.9 sucrose, 5 EGTA and 10 HEPES, pH adjusted to 7.4 with 142 
NaOH. Ca2+ free Hanks cell dispersal solution: NaCl (125), KCl (5.36), glucose (10), 143 
sucrose (2.9), NaHCO3 (15.5), KH2PO4 (0.44), Na2HPO4 (0.33), N-[2-144 
Hydroxyethylpiperazine]-N'-[2-ethanesulfonic acid] (HEPES; 10) pH adjusted to 7.4 with 145 
NaOH. Krebs solution: NaCl (120), KCl (5.9), NaHCO3 (1.2), glucose (5.5) CaCl2 (12.5), 146 
MgCl2 (6) pH maintained at 7.4 by bubbling with 95% O2-5% CO2. K+ pipette solution 147 
(whole cell): 132 K+, 110 gluconate, 21 Cl-, 2 Na+, 0.5 Mg2+, 1 ATP, 0.1 GTP, 2.5 148 
phosphocreatine, 5 HEPES and 1 EGTA; pH adjusted to 7.2 with KOH. K+ pipette solution 149 
(perforated patch): 133 K+, 135 Cl-, 1 Mg2+, 0.5 EGTA and 10 HEPES; pH adjusted to 7.2 150 
with KOH. 151 
During experiments, the dish containing the cells was superfused with Hanks solution.  In 152 
addition, the cell under study was continuously superfused with Hanks solution by means of 153 
a close delivery system consisting of a pipette (tip diameter 200 µm) placed approximately 154 
300 µm away.  This could be switched, with a dead-space time of around five seconds, to a 155 
solution containing a drug. All experiments were carried out at 36±1oC. 156 
 157 
Statistics 158 
Experiments on freshly dispersed RUSMCs were usually carried out on a minimum of 3 159 
animals.  In all experiments ‘n’ refers to the number of cells studied. Summary data are 160 
presented as the mean ± S.E.M and statistical comparisons were made on raw data using 161 
students paired t-test, unpaired t-test or ANOVA as appropriate, taking p<0.05 level as 162 
significant. In the Figures * represents p<0.05, ** represents p<0.01 and *** represents 163 
p<0.001. 164 
 165 
Total RNA isolation and RT-PCR 166 
Total RNA was prepared from brain and urethral smooth muscle strips using the TRIZOL 167 
method (Invitrogen) as per manufacturers instructions and treated with DNase (Stratagene). 168 
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First strand cDNA was prepared from the RNA preparations using the Superscript II RNase 169 
H reverse transcriptase (Invitrogen); 200 µg ml–1 of random hexamer was used to reverse 170 
transcribe the RNA sample. The cDNA formed from the reverse transcription reaction was 171 
amplified with specific primers by RT-PCR. This was preformed in a 25 µl reaction 172 
containing 12.5 µl Amplitaq Gold Mastermix (Applied Biosystems), 8.5 µl of water, 1 µl of 173 
sense and antisense primers (at a concentration of 10 µM) and 2 µl of template cDNA. All 174 
reactions were performed in a Techne TC-512 gradient thermal cycler. The amplification 175 
profile for all primer pairs were as follows: 95°C for 5 min, followed by 35 cycles of 95°C for 176 
30 s and 56°C for 1 min, 72°C for 1 min, with a final extension step at 72°C for 7 min. The 177 
amplified products were separated by electrophoresis on a 2% agarose–1 x TAE (Tris, acetic 178 
acid, EDTA) gel and the DNA bands were subsequently visualized by ethidium bromide 179 
staining and documented on an INGENIUS gel documentation system (Syngene Bio 180 
Imaging). 181 
 182 
Quantitative Real-Time PCR 183 
Quantitative Real-Time RT-PCR (qPCR) was performed in a 25 µl reaction containing 12.5 184 
µl SYBR Green Mastermix (Applied Biosystems), 8.5 µl of water, 1 µl of sense and antisense 185 
primers (at a concentration of 10 µM) and 2 µl of template cDNA. The reaction was carried 186 
out using a Techne – Quantica Real Time Thermal Cycler.  The thermal protocol for the 187 
qPCR was identical to that described above. We used the relative quantification method (3), 188 
using the housekeeper gene, β-actin as an internal standard. Only primers with 90-110% 189 
efficiency were used for these experiments, however differential primer efficiencies were 190 
accounted for in this analysis by generation of standard curves (range 1:2 – 1:100 dilution). 191 
Standard curves were generated for Kv subunit and β-actin mRNA from regression analysis 192 
of the mean values of RT-PCRs for the log10 diluted cDNA. Unknown quantities relative to 193 
the standard curve for the Kv primers were calculated, yielding transcriptional quantification 194 
of Kv cDNA relative to β-actin. Each cDNA sample was tested in triplicate and cDNA was 195 
obtained from a minimum of three different animals. Mean values generated at individual 196 
time points were compared by ANOVA and statistical analyses were performed using 197 
GraphPad Prism version 4 (GraphPad Software, San Diego, CA, USA). In order to validate 198 
that the double stranded DNA fluorescence was primarily amplicon-based (as opposed to 199 
primer dimer), melting curve analysis was employed by ramping the temperature from 70 °C 200 
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to 90 °C which resulting in melting of the double stranded DNA.  If one distinct peak was 201 
present, this was consistent with one PCR product resulting from the reaction. 202 
 203 
Primer design 204 
All primers for PCR were designed against the published rabbit sequence except for Kv1.7, 205 
which was designed against the human sequence. In each case the number in parentheses 206 
represents the GenBank accession number. 207 
 208 
Kv1.2 (NM_001082722.1):  209 
sense nucleotide nt 168-183, GCAGCTGGAAGGCGTA 210 
antisense nt 584-568, TCTCCATGGCCTCCTCA.  211 
Amplicon, 417 base pairs (bp).  212 
 213 
Kv1.3 (NM_001171129.1):  214 
sense nucleotide nt 343-358, AACGTGCCCATCGACA.  215 
antisensent 740-756, GAGCAGCTCGAAGGAGA.  216 
Amplicon 414 bp.  217 
 218 
Kv1.7 (AY779768.1):  219 
sense nucleotide nt 637-659, TGCCCTTCAATGACCCGTTCTTC. 220 
antisense nt 886-864, AAGACACGCACCAATCGGATGAC.  221 
Amplicon 250 bp.  222 
 223 
Kv2.1 (NM_001082087.1):  224 
sense nt 1060-1079, GTCCAGATCTTCCGCATCAT. 225 
antisense nt 1255-1236, ACTTGGTGTCGTCCTCATCC.  226 
Amplicon, 196 bp.  227 
 228 
Kv2.2 (NM_001082137.1):  229 
sense nt 1561-1580, CGAAGTATGGAACTGATCGA.  230 
antisense nt 1726-1707, CCTCCTGGTACTTATTCTCA.  231 
Amplicon, 166 bp.  232 
 233 
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Kv4.2 (NM_001082118.1):  234 
sense nt 546-565, CATGGCCCTGGTGTTCTACT.  235 
antisense nt 738-719, CAGCAAGTACTCGACGGTGA.  236 
Amplicon 193 bp. 237 
 238 
Kv4.3 (NM_001082717.1):  239 
sense nt 1573-1592, ATGCAGAACTACCCGTCCAC.  240 
antisense nt 1783-1764, GATTAAGGCTGGAGCGACTG.  241 
Amplicon 211 bp. 242 
 243 
KV5.1 (XM_002722391):  244 
sense nucleotide (nt) 732-750, 5’-GCCCAACAAGCTGCACTTC-3’ 245 
antisense nt 854-834, 5’-ACGTTGGTCAGCTCCATCATG-3’.  246 
Amplicon, 123 bp.  247 
 248 
KV6.1 (XM_002722694):  249 
sense nucleotide (nt) 272-290, 5’-AGCTCAAGGCCTGCACCAA-3’ 250 
antisense nt 362-344, 5’-GGGTTGCGGTCGAAGAAGA-3’.  251 
Amplicon, 111 bp.  252 
 253 
KV6.3 (XM_002709903):  254 
sense nucleotide (nt) 799-820, 5’-ATCTCCGTGCTGATGACAGTGT-3’ 255 
antisense nt 919-900, 5’-TGAAGTGACGGGCAAGCTTA-3’.  256 
Amplicon, 121 bp. 257 
KV9.1 (XM_002721207):  258 
sense nucleotide (nt) 1025-1043, 5’-TCTCCGGTGTGGCCTACAC-3’  259 
antisense nt 1135-1117, 5’-CATCCCCGTAGCCCACTGT-3’.  260 
Amplicon, 111 bp.  261 
 262 
KV9.2 (XM_002710709):  263 
sense nucleotide (nt) 596-617, 5’-GCTCCATCATCACCATGTGTCT-3’ 264 
antisense nt 714-694, 5’-GAACCAGGCTATGCCAAAGTG-3’.  265 
Amplicon, 119 bp.  266 
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 267 
KV9.3 (NM_001082652): sense nucleotide (nt) 796-817,  268 
5’-TTCTATGCCACGTTGGCAGTAG-3’  269 
antisense nt 916-897, 5’-GCCGGGCAAGCTTTAGAATT-3’.  270 
Amplicon, 121 bp. 271 
 272 
β-actin (AF404278),  273 
sense nucleotide (nt) 1-20, 5'-GATTCACCATGGATGATGAT-3',  274 
antisense  nt 238-219, 5'-ACTAGTGATTGCTGCTCGAT-3'.  275 
Amplicon. 238 bp 276 
 277 
HEK293 stable transfection with KV2.1 and KV2.2 278 
Total RNAs were extracted from homogenates of male New Zealand white rabbit urethra (16 279 
weeks old) using the acid guanidium thiocyanate-phenol method, followed by digestion with 280 
RNase-free DNase. Reverse-transcription was performed using SuperScript ® II-RNase- 281 
(Invitrogen) according to Invitrogen’s protocol. The resulting cDNA products were amplified 282 
with gene-specific primers. To obtain the full-length KV2.1 and KV2.2 clones from rabbit 283 
urethra cDNAs, oligonucleotide primers were designed using Genetyx-Win software (Ver. 284 
4.0, Genetyx Corp., Tokyo, Japan) as follows: KV2.1 (+):5’-285 
CTCCGAATTCTCGAGTGACAGCGGCCT-3’ corresponding to nucleotides 122-138 and (-286 
):5’-CTCCTCTAGATCAGAGGAACAGCCCCCCCACT-3’ corresponding to nucleotides 287 
2824-2803 of rabbit KV2.1 (GenBank accession number NM_001082087, CDS: 175-2751); 288 
KV2.2 (+):5’-CTCCAAGCTTAACTGTCATGCTTGCCCCG-3’ corresponding to 289 
nucleotides 98-116 and (-):5’-CTCCTCTAGACTAGTCACATGCTGGTCTCCCG-3’ 290 
corresponding to nucleotides 2923-2902 of rabbit KV2.2 (NM_001082137, CDS: 184-2919). 291 
The sequences underlined are EcoR I (GAATTC), Hind III (AAGCTT) and Xba I 292 
(TCTAGA) recognition sites which were added to insert the PCR products into vector 293 
plasmid DNA, pcDNA3.1(+)/Neor or pcDNA3.1(+)/Zeor (Invitrogen) in the proper 294 
orientation. The thermal cycler program used for PCR amplification included a 0.5 min 295 
denaturation step at 94 oC, a 0.5 min annealing step at 55 oC and a 3 min primer extension 296 
step at 72 oC for 40 cycles. Reaction products were separated on 1 % agarose gels in Tris 297 
acetate/EDTA buffer and were recovered from gel fragments using GENECLEAN II 298 
(Qbiogene, Carlsbad, CA, USA). After restriction enzyme digestion, the amplified products 299 
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for Kv2.1 and Kv2.2 were ligated into EcoR I/Xha I and Hind III/Xba I recognition sites of 300 
pcDNA3.1(+)/Neor and pcDNA3.1(+)/Zeor, respectively (pcDNA-rbKV2.1, pcDNA-301 
rbKV2.2). Sequence homology of cloned cDNAs was confirmed by DNA sequence analysis 302 
with an ABI PRISM (model 310) (Applied Biosystems, Foster City, CA, USA). The HEK-303 
293 cell line was obtained from Health Science Research Resources Bank (HSRRB) (Tokyo, 304 
Japan) and maintained in complete DMEM containing penicillin (100 units/ml) and 305 
streptomycin (100 μg/ml). A mammalian expression vector was used for stable transfection 306 
by calcium phosphate precipitation and then 1 mg/ml geneticine (Invitrogen) (for pcDNA-307 
rbKV2.1) and zeocine (Invitrogen) (for pcDNA-rbKV2.2)-resistance cells were selected and 308 
identified by RT-PCR analysis, respectively. 309 
 310 
Immunocytochemistry  311 
Single cells were plated on 35 mm glass bottom culture dishes and culture medium was 312 
removed from HEK cells prior to staining.  Cells were washed in PBS and fixed in a solution 313 
containing 2% paraformaldehyde (PFA, for Kv2.1 and Kv2.2 antibodies) made up in 314 
phosphate buffered saline (PBS) or acetone (for Kv9.3 antibody) for 20-30 mins.  The fixative 315 
was then removed and cells were washed 3 times in PBS at 5 min intervals.  Cells were 316 
permeabilised in a PBS solution containing 0.3% Triton X and 3% goat serum for 10 mins.  317 
Cells were again washed in 3 times with PBS at 5 min intervals. 318 
Primary antibodies were prepared as per manufacturer’s instructions and optimized for use 319 
with this cell type.  The primary antibodies (Alomone Laboratories, Israel) were incubated 320 
with the cells overnight at 4°C in a humidified box.  Primary antibody was removed and cells 321 
were washed a further 3 times with PBS.  The secondary antibody, Alexa 488 anti-rabbit 322 
(Invitrogen, Kv2.1 & Kv2.2), or anti-goat (Invitrogen, Kv9.3) was prepared at a 1:1000 323 
dilution in 1 ml PBS with 3% goat serum.  Cells were incubated in secondary antibody at 4°C 324 
for 1 hour.  Cells were washed with PBS 5 times prior to imaging.  Dishes were mounted 325 
onto and imaged with an upright Axioskop 2 LSM 510 Meta confocal microscope (Zeiss).  326 
Cells were excited with a 488 nm laser and emission was detected at  >505 nm. 327 
 328 
Western Blotting 329 
Protein fractions of the plasma membrane were prepared from HEK293 cells according to the 330 
Alomone Laboratory protocol (http://www.alomone.com). Protein fractions were solubilized 331 
with sample buffer including 1% SDS and subjected to SDS-PAGE (10%). The blots were 332 
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incubated with anti-KV2.1 or anti-KV2.2 antibody (Alomone Labs, Jerusalem, Israel), and 333 
then incubated with anti-rabbit horseradish peroxidase-conjugated IgG (Chemicon, 334 
Temecula, CA, USA). An enhanced chemiluminescence detection system (Amersham 335 
Biosciences, Piscataway, NJ, USA) was used for the detection of the bound antibody. 336 
Resulting images were analyzed by a LAS-1000 device (Fujifilm, Tokyo, Japan). Primary 337 
antibody preincubated with excess antigen was tested for specificity confirmation. 338 
 339 
Tension Recordings 340 
Strips of smooth muscle (8 x 1 x 1 mm) were removed from the rabbit urethra, placed in 341 
water-jacketed organ baths maintained at 36±1°C, and perfused with warmed Krebs solution 342 
that was bubbled with 95% O2-5% CO2 and contained atropine (1 µM), guanethidine (1 µM) 343 
and NG-Nitro-L-arginine (NO-ARG, 100 µM) to block any contribution from 344 
neurotransmitters. Strips were adjusted to a tension of 2–4 mN and allowed to equilibrate for 345 
50 min before experimentation began. Contractions were measured using the multi channel 346 
Myobath system and data was acquired using DataTrax 2 software (WPI, Europe).  347 
 348 
Drugs used:  349 
Amphotericin B, atropine, guanethidine, NG-Nitro-L-arginine, α-dendroxin, κ-dendrotoxin  350 
and Pen A were all obtained from Sigma. Stromatoxin and margatoxin were supplied by 351 
Alomone Labs, Israel. Iberiotoxin was obtained from Tocris. All drugs were made up in the 352 
appropriate stock solution before being diluted to their final concentrations in Hank’s 353 
solution. 354 
 355 
RESULTS 356 
Using our dispersal procedure, relaxed urethral smooth muscle cells (RUSMC) and 357 
interstitial cells (ICC) could be reliably isolated from the rabbit urethra. The SMC were 358 
easily distinguished from the ICC as they were unbranched, spindle shaped, and contractile.  359 
 360 
Blockade of BK current unmasks a Kv current in RUSMC. 361 
In this set of experiments, currents were recorded using the perforated patch configuration of 362 
the patch clamp technique. Under voltage clamp at –60 mV, the SMC were electrically 363 
quiescent as demonstrated previously (33). When cells were depolarized from –60 mV to +40 364 
mV for 500 ms, large transient and sustained outward currents were evoked (Figures 1A and 365 
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1C). We first examined the effects of the selective large conductance Ca2+ activated K+ (BK) 366 
channel toxin, iberiotoxin (IbTx, 300 nM) on these currents in order to ascertain if they were 367 
due to activation of BK channels. As Figure 1A suggests, application of IbTx abolished the 368 
transient current and also reduced the amplitude of the sustained current. A summary 369 
barchart for 3 similar experiments is shown in Figure 1B. Under control conditions, the peak 370 
current was 1767 ± 307 pA at +40 mV and this was significantly reduced in IbTx to 622 ± 371 
142 pA (p<0.01, paired t-test). We also examined the effects of the BK channel blocker Pen 372 
A, 100 nM) on the outward current evoked by a step to +40 mV and as Figure 1C suggests, 373 
blockade of the BK current unmasked a slowly activating, sustained outward current. Figure 374 
1D shows summary data obtained from 5 cells in which Pen A significantly reduced the peak 375 
outward current at +40 mV from 1456 ± 258 pA to 438 ± 179 pA (p<0.05). Taken together, 376 
these data suggest that the transient current and a component of the sustained current in 377 
urethral SMC is due to the activation of BK channels and when this is blocked, a slowly 378 
activating Kv current is unmasked. In a separate set of experiments the effects of IbTx were 379 
assessed after Pen A application and it was found to have no additional effect (n=5). 380 
Similarly, application of Pen A (100 nM) after application of IbTx (300 nM) failed to further 381 
reduce the currents (n=3), suggesting that Pen A selectively blocks BK current in these cells.  382 
To study the Kv current in more detail, all subsequent voltage clamp experiments on RUSMC 383 
were carried out in the presence of 100 nM Pen A.  384 
The upper panel of Figure 1E shows the voltage protocol used to evoke Kv currents in 385 
RUSMC, which involved holding the cell at –60 mV and depolarizing it from –80 mV to +50 386 
mV in 10 mV steps for 500 ms before repolarising back to –40 mV. These experiments were 387 
carried out in Ca2+ free Hanks solution to remove contaminant Ca2+ currents (6, 18). As the 388 
lower panel of Figure 1E suggests, outwardly rectifying, sustained currents were recorded in 389 
response to these depolarizing voltage steps and large, slowly-deactivating, tail currents were 390 
evoked upon repolarisation to –40 mV. Figure 1F shows a summary current voltage (IV) plot 391 
taken from 18 cells and illustrates that the Kv current was activated at potentials positive to –392 
50 mV.  393 
 394 
Evidence that Kv1 channels do not contribute to the Kv current in rabbit urethral 395 
myocytes. 396 
Given that Kv1 channels have been shown to play an important role in smooth muscle 397 
excitability (1, 3, 4, 8, 16, 32, 38), we first determined if these channels contributed to this 398 
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current by examining the effects of a variety of Kv1-specific toxins on currents evoked by 399 
steps from –60 to +40 mV. As Figure 2A illustrates, application of the Kv1.1/ Kv1.2/ Kv1.6 400 
blocker α-dendrotoxin (100 nM, gray trace) did not inhibit the current, even though it has 401 
been shown to block Kv1 channels in the nanomolar range (15, 29). In three similar 402 
experiments, application of α-dendrotoxin failed to significantly alter the current (control 403 
was 575 ± 53 pA compared with 617 ± 45 pA in α-dendrotoxin). Similarly, the Kv1.1 blocker 404 
κ-dendrotoxin did not block the current (Figures 2C & 2D, 515 ± 61 pA in control compared 405 
to 498 ± 57 pA in toxin, n=5). Application of the pan-Kv1 blocker margatoxin (100nM) was 406 
also without effect as shown in Figure 2E. In three experiments, application of this toxin had 407 
no significant effect on the Kv current (control was 686 ± 99 pA compared to 669 ± 102 pA, 408 
n.s.). Taken together, these data suggest that the Kv current in rabbit urethral myocytes is 409 
unlikely to be due to homomers or heteromers of Kv1 subunits. 410 
 411 
Evidence that Kv2 channels do contribute to the Kv current in rabbit urethral myocytes. 412 
To test if Kv2 channels were functionally expressed in rabbit urethral smooth muscle cells, 413 
we examined the effects of the Kv2 channel gating modifier, ScTx on families of currents 414 
evoked by steps from –80 to +50mV in 10 mV increments from a holding potential of –100 415 
mV. When cells were stepped back to –60 mV, outward tail currents were difficult to resolve. 416 
Escoubas et al., (2002) have previously shown that 100 nM ScTx reduced the amplitude of 417 
Kv2.1 currents in COS cells evoked by a step to +50 mV by ~75%. As Figures 3B & 3C 418 
demonstrate, application of 100 nM ScTx reduced the amplitude of the RUSMC currents. 419 
Figure 3D shows summary IV plots of the Kv currents in the absence (open circles) and 420 
presence (filled circles) of ScTx obtained from 12 cells. ScTx significantly reduced the 421 
amplitude of currents at potentials positive to –30 mV and the toxin appeared to block more 422 
effectively at negative membrane potentials. Thus, at 0 mV the peak current was reduced by 423 
~70% from 306 ± 67 pA to 94 ± 20 pA compared to only 50% blockade at +50 mV, where 424 
the currents were reduced from 961 ± 182 pA to 460 ± 93 pA in the presence of ScTx. 425 
We next used RT-PCR to examine the expression profile of message for the Kv2 family 426 
members. As Figure 4A demonstrates, PCR products for Kv2.1 (upper panel, expected 427 
amplicon=196 bp) and Kv2.2 (lower panel, expected amplicon=146 bp) were amplified from 428 
brain tissue (Br) and strips of urethra taken from 4 animals (Ur1-Ur4), but were absent in the 429 
non-template controls (NTC). To examine the quantitative expression of the two Kv2 430 
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subtypes in urethra (relative to β-actin), we performed qPCR on urethral strips taken from 6 431 
animals.  As Figure 4B suggests, there was robust expression of Kv2.1 and Kv2.2 mRNA, but 432 
there was no significant difference in transcriptional expression levels between the two 433 
subtypes (paired t-test). When we examined the transcriptional expression of Kv1.2, Kv1.3, 434 
Kv1.7, Kv4.2 and Kv4.3 in three strips, we found that they were approximately 3-fold lower 435 
than either of the Kv2 family members. 436 
Given that the transcriptional expression data were obtained from tissue strips, rather than 437 
isolated cells, it is possible that the data reflect Kv2 transcriptional expression in nerves or 438 
blood vessels in the urethra. Therefore, to test if Kv2 was expressed in isolated RUSMC, we 439 
next performed immunocytochemistry with specific anti-Kv2.1 and anti-Kv2.2 antibodies. As 440 
Figure 4C shows, membrane limited staining was obtained only when primary and secondary 441 
antibodies (Figure 4Cii) raised against Kv2.1 were present. No immunoreactivity to Kv2.1 442 
was detected when the antibody was incubated with an excess of antigen (data not shown). 443 
When cells were incubated with monoclonal mouse anti-Kv2.2 primary antibodies 444 
(Antibodies Inc., Davis, USA) and stained with a goat anti-mouse Alexa 488 secondary 445 
antibody, some immunoreactivity was observed (Figure 4Dii).  Patchy staining appeared to 446 
be largely confined to membrane-bound areas although some intracellular staining was also 447 
present throughout the cells.  It is unclear if this was a result of poor antibody interaction or 448 
reflective of actual Kv2.2 distribution.  However, secondary controls in which the primary 449 
antibody was omitted showed no immunoreactivity (Figure 4 Div). 450 
 451 
Comparison of the native ScTx sensitive current with Kv2.1 and Kv2.2 channels cloned 452 
from the rabbit urethra. 453 
Having established that the majority of the Kv current in RUSMC was ScTx sensitive, we 454 
next cloned Kv2.1 and Kv2.2 from the rabbit urethra and stably expressed them in HEK 293 455 
cells. We performed immunocytochemistry with specific anti-Kv2.1 and anti-Kv2.2 456 
antibodies detailed above on each clone of the Kv2 channel. As Figure 5A shows, membrane 457 
limited staining of HEKKv2.1 cells was obtained only when primary and secondary antibodies 458 
(Figure 5Aii) raised against Kv2.1 were present. No immunoreactivity to Kv2.1 was detected 459 
when the antibody was incubated with an excess of antigen (data not shown). Similarly, the 460 
HEKKv2.2 were only immunopositive when incubated with both primary and secondary 461 
antibodies (Figure 5Bii). 462 
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We confirmed the molecular weights of KV2.1 and KV2.2 proteins cloned from rabbit urethra 463 
in HEK cells by Western blotting. Figures 5C & 5D show bands around 100 and 110 kDa 464 
were detected, consistent with the molecular weights predicted from rabbit KV2.1 (95 kDa) 465 
and KV2.2 (102 kDa), respectively in the stably-transfected cells (middle lanes), but not the 466 
vector-transfected HEK cells (left lanes). This immunoreactivity was decreased following 467 
preincubation of anti-KV2.1 and anti-KV2.2 antibodies with excess antigens, respectively 468 
(right lanes). 469 
To compare the biophysical and pharmacological properties of the native Kv current with 470 
currents in HEKKv2.1 and HEKKv2.2 cells we used the ruptured patch configuration of the 471 
patch clamp technique. As a control, current voltage (IV) relationships were determined from 472 
non-transfected HEK cells to measure the amplitude of endogenous currents. In three cells 473 
the mean amplitude of currents evoked by a depolarizing step to +60 mV was +380 ± 126 474 
pA, suggesting that the endogenous currents were unlikely to contaminate our recordings 475 
significantly.  476 
Figure 6 shows that HEKKv2.1, HEKKv2.2 and RUSMC Kv currents had similar kinetics and 477 
voltage dependent activation. However a much slower tail current was observed in the native 478 
RUSMC (Figure 6A) in response to a repolarising step to –40 mV, compared to the HEKKv2.1 479 
and HEKKv2.2 cells. Figures 6A and 6B show typical currents and summary activation curves 480 
respectively, of the ScTx-sensitive (100 nM) difference currents obtained in freshly dispersed 481 
RUSMC in which the mean activation V1/2 was –7 ± 5 mV (n=12). This was not significantly 482 
different to the activation V1/2 obtained from HEKKv2.1 (0 ± 5 mV, n=10, Figure 6D) or 483 
HEKKv2.2 cells (0±1 mV, n=8, Figure 6F).  484 
To examine the kinetics of the currents in more detail, we first measured the activation time 485 
constants of the RUSMC ScTx-sensitive currents and compared these with the HEKKv2.1 and 486 
HEKKv2.2 currents. As Figure 7A suggests, the activation time constants of all three currents 487 
decreased with depolarization. The HEKKv2.1 currents (filled circles, n=10) had slower 488 
activation time constants than HEKKv2.2 (filled squares, n=10) at potentials negative to 0 mV. 489 
However at positive potentials, the activation time constants of the currents in HEKKv2.1 and 490 
HEKKv2.2 cells were indistinguishable from each other, and both were significantly different 491 
to the RUSMC (p<0.05, ANOVA). Similarly, as shown in Figure 7B, the deactivation time 492 
constants in HEKKv2.1 (26 ± 14 ms, n=10, range 6-122 ms), and HEKKv2.2 cells (9 ± 1 ms, 493 
n=10, range 7-14 ms) were not significantly different, although there was more variation in 494 
the HEKKv2.1 currents. A much more slowly deactivating tail current was evident in the 495 
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RUSMC (Figure 7B, τ=322 ± 91 ms, n=14, p<0.05, ANOVA). There was considerable 496 
variation in the rate of deactivation of the RUSMC Kv current and the time constant in these 497 
cells ranged from 66 ms to 1300 ms. These data suggest that there may be some 498 
heterogeneity in the ion channel expression perhaps caused by the variable expression of 499 
silent Kv subunits. 500 
To assess if the slow tail current deactivation in RUSMC was due to the presence of silent Kv 501 
subunits in RUSMC, we next compared the quantitative transcriptional expression of a 502 
number of silent family members. As Figure 7C suggests transcriptional expression of Kv9.3 503 
was highest of all the members tested. To check if the isolated RUSMC showed functional 504 
expression of this modulatory subunit, we used immunocytochemistry with specific anti-505 
Kv9.3 antibodies. As Figure 7D shows, membrane limited staining was obtained only when 506 
primary and secondary antibodies (Figure 7Dii) raised against Kv9.3 were present, suggesting 507 
that this regulatory Kv subunit was present in RUSMC. 508 
 509 
We next examined the voltage dependence of steady state inactivation of the three currents 510 
using a standard double pulse protocol. Cells were subjected to 10s conditioning steps from –511 
100 mV to 0 mV in 10 mV increments before stepping to a test potential of +40 mV for 500 512 
ms to maximally activate the Kv current. Figures 8A, C and E shows typical recordings of the 513 
currents obtained by the step to +40 mV following the preceding conditioning potentials in 514 
RUSMC, HEKKv2.1 and HEKKv2.2 cells respectively. When these data were normalized, 515 
plotted and fitted with the Boltzmann equation, inactivation V1/2’s of –56±3 mV, -55±3 mV 516 
and –30±3 mV were obtained for the native RUSMC (Figure 8B, n=9), Kv2.1 (Figure 8D, 517 
n=13) and Kv2.2 (Figure 8F, n=11) currents respectively. There was no significant difference 518 
in the inactivation V1/2 between the native RUSMC current and the HEKKv2.1 current, but 519 
both were significantly different to the HEKKv2.2 current (p<0.05, ANOVA). These data 520 
suggest that the steady state inactivation properties of the native RUSMC Kv currents are 521 
more similar to HEKKv2.1 than HEKKv2.2 currents.  522 
 523 
To establish the sensitivity of the currents to ScTx, we examined the effects of increasing 524 
concentrations on currents evoked by a step to +40 mV. Figures 9A, C & E show typical 525 
currents obtained in the absence and presence of increasing concentrations of ScTx in 526 
RUSMC, HEKKv2.1 and HEKKv2.2 cells respectively. Unfortunately, we did not use 527 
sufficiently high concentrations of ScTx to permit the construction of full concentration 528 
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effect curves, but the data show that ScTx caused a concentration dependent reduction of the 529 
currents. When the summary data were plotted for RUSMC (Figure 9B), HEKKv2.1 (Figure 530 
9D) and HEKKv2.2 currents (Figure 9F), we estimated the IC50 to be ~130 nM, ~150 nM and 531 
~70 nM respectively.  532 
 533 
Contribution of the ScTx sensitive current to evoked action potentials in rabbit urethral 534 
myocytes. 535 
Having established that the majority of the Kv current in RUSMC was ScTx sensitive and 536 
likely to be due to Kv2.1 subunits, we next assessed its contribution to electrical activity by 537 
examining the effects of ScTx on evoked action potentials (AP). In these experiments the 538 
perforated patch configuration of the patch clamp technique was used and a small 539 
hyperpolarizing current was continually injected to bring the membrane potential to ~-60 540 
mV. Figure 10A shows the results of a typical current clamp experiment in which an AP was 541 
evoked by injecting 100 pA current for 40 ms into a RUSMC. This elicited an AP that 542 
consisted of a rapid upstroke, a rapid repolarisation and an after-hyperpolarisation. When 543 
ScTx (300 nM) was applied and the AP was evoked (green trace, Fig 10A) neither the 544 
amplitude or duration of the AP or after-hyperpolarisation were significantly altered.   545 
One explanation for this lack of effect, could be due to differences in the amplitude and 546 
activation kinetics of the BK and Kv current.  For example, a depolarising step to 0 mV 547 
evokes a transient BK current of ~ 800 pA in amplitude in RUSMC and this current reaches 548 
peak amplitude in less than 20 ms. In contrast, depolarisation evokes a Kv current in these 549 
cells that is ~ 250 pA in amplitude at 0 mV (Figure 1F) and takes approximately 100 ms to 550 
fully activate. Thus, at the peak of the AP, the Kv current would only reach ~ 25% of its peak 551 
amplitude, due to the slow time course of its activation. We might therefore expect that the 552 
contribution of the Kv current is only observed when the BK current is absent. To test this 553 
directly, we first blocked the BK current with Pen A and then observed the effects of ScTx 554 
application on the AP.  Figure 10B shows a typical example of such an experiment where 555 
Pen A (100 nM, Figure 10B, red line) increased the amplitude and duration of the AP.  556 
Subsequent application of ScTx (300nM, green line) further prolonged the AP. Figure 10C 557 
shows summary data from 5 cells in which the duration of the AP was recorded under control 558 
conditions (open bars), in the presence of Pen A (100 nM, red bar) and in the presence of Pen 559 
A and ScTx (300 nM, green bar). Pen A significantly increased the mean duration of the AP 560 
from 24 ± 3 ms to 104 ± 17 ms (p<0.05) and this was further increased to 220 ± 61 ms 561 
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(p<0.01) following ScTx application. Although ScTx prolonged the AP, it had very little 562 
effect on its peak amplitude (Figure 10D).  563 
 564 
Contribution of the ScTx sensitive current to contractile activity in strips of rabbit 565 
urethra. 566 
To examine the contribution of Kv2 currents to spontaneous mechanical activity, we recorded 567 
isometric tension from strips of urethra smooth muscle and examined the effects of ScTx 568 
(100 nM). All experiments were carried out in the presence of atropine (1 μM), guanethidine 569 
(1 μM) and NO-ARG (100 μM) to block any contribution from neurotransmitters. In 570 
seventeen strips taken from 8 animals, small spontaneous contractions (mean amplitude 0.48 571 
± 0.18 mN, range 0.1- 2.8 mN) occurred at a mean frequency of 4.4 ± 1.1 min-1 (range 0 - 572 
14.2 min-1). Figure 11A shows an example of spontaneous mechanical activity in the absence 573 
(upper panel) and presence of 100 nM ScTx (lower panel), where there was a small increase 574 
in the amplitude and frequency of contractions following ScTx application for 30 minutes. 575 
Figures 11B and C show summary data for 7 similar experiments in which the mean 576 
contraction amplitude and frequency respectively, were measured in the absence (open bars) 577 
and presence (closed bars) of ScTx (100 nM) for up to 30 minutes. Neither contraction 578 
amplitude nor frequency, were significantly altered in the presence of ScTx (p>0.05, paired t-579 
test).  580 
We next compared the effect of ScTx on contractility in the presence of Pen A (100 nM, 581 
Figure 11D). Application of Pen A by itself increased the amplitude of contraction from 0.42 582 
± 0.3mN to 0.93 ± 0.2 mN and contraction frequency from 3 ± 1.2 to 6.7 ± 1.3 min-1 (n=10, 583 
p<0.05, ANOVA).  584 
Subsequent application of ScTx in the continued presence of Pen A (Figure 11D, lower 585 
panel) significantly increased contraction amplitude and frequency, demonstrating that 586 
blockade of Kv2 channels under these conditions, dramatically affects urethral contractility. 587 
Summary data for ten experiments shown in Figure 11E & F demonstrated that application of 588 
Pen A and ScTx significantly enhanced contraction amplitude to 3.2 ± 0.7 mN and frequency 589 
to 10.1 ± 1.4 min-1 (black bars, p<0.05, ANOVA).  590 
591 
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DISCUSSION 592 
The aim of this study was to characterise the Kv current in rabbit urethral smooth muscle 593 
cells, examine its molecular identity and assess its contribution to the action potential and 594 
spontaneous contractile activity. We found that approximately 30% of the net outward 595 
current at 40 mV was carried via an IbTx and Pen A-insensitive current that activated and 596 
inactivated slowly at physiological potentials. Our results suggest that the Kv current shares a 597 
number of features with Kv2.1 channels cloned from this tissue and demonstrate that its 598 
blockade can significantly prolong the action potential, but only when the transient BK 599 
current is blocked.  600 
Although Kv1 channels have been shown to play an important role in a variety of smooth 601 
muscles (1, 3, 4, 8, 14, 16, 38), it appears unlikely that they contribute significantly to the Kv 602 
current in RUSMC, since they were unaffected by a variety of Kv1 specific toxins. The 603 
current was insensitive to margatoxin, κ- and α-dendrotoxin which have been shown 604 
previously to block Kv1 family members (15, 16, 29) at much lower concentrations than 605 
those used in this study. 606 
The data presented here suggest that Kv2 channels are likely to contribute significantly to the 607 
Kv current in urethral smooth muscle. Thus, transcriptional expression for both Kv2.1 and 608 
Kv2.2 was detected in whole urethral strips and immunocytochemical data suggests that both 609 
Kv2.1 and Kv2.2 channels are located in the membranes of freshly dispersed RUSMC. 610 
Furthermore, the native Kv current in the present study was reduced in a concentration 611 
dependent manner by the Kv2 gating modifier ScTx (2, 10, 41) with an IC50 of ~130 nM, 612 
consistent with the idea that Kv2 subunits underlie the Kv current in these cells. However, it is 613 
important to note that ScTx can also block some Kv4 family members (10), but we feel that 614 
these effects were unlikely to account for our results given that the Kv current in RUSMC did 615 
not share any of the biophysical properties of the ‘A’ type currents encoded by Kv4 family 616 
members (12). It is possible that other Kv channel subtypes may also contribute to the 617 
delayed rectifier current in RUSMC, but we have not examined this in the present study since 618 
~70% of the Kv current was abolished at physiological potentials by ScTx. 619 
 620 
When we examined the biophysical properties of the Kv current in RUSMC, we found that 621 
the currents activated with a V1/2 of –7 mV, which is similar to those obtained in native cells 622 
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and heterologous expression systems expressing either Kv2.1 channels (4, 20, 21, 22, 25, 37, 623 
39, 41) or Kv2.2 channels (19).  Interestingly, the inactivation V1/2 for the Kv current in 624 
RUSMC was -56±3 mV and although this value is similar to that shown for Kv2.1 in native 625 
pyramidal neurons (-62 mV, (11)) and bladder SMCs (-61 mV, (37)), it is 25 to 35 mV more 626 
negative than that recorded from Kv2 channels in various expression systems (20, 22, 25, 27, 627 
30). The observed differences in the V1/2 of inactivation of Kv2 channels recorded in native 628 
cells and heterologous expression systems have been well documented and are thought to be 629 
due to the presence of additional electrically silent Kv subunits in native cells (23, 26, 41) or 630 
differences in the phosphorylation status of the channel (21, 22). The silent Kv subunits 631 
comprise the Kv5, Kv6, Kv8 and Kv9 families, which cannot form functional ion channels 632 
when expressed alone, but can modify the biophysical properties when co-expressed with the 633 
other pore forming Kv subunits (26, 27, 30, 31, 39, 41, 42). Thus, co-expression of Kv2.1 634 
with the silent subunit Kv9.3 has been shown to slow deactivation, shift the activation V1/2 by 635 
~-20 mV and alter the inactivation V1/2 by ~-15 mV (26, 41). Similarly, co-expression of 636 
Kv2.1 with either Kv5.1 or Kv6.1 shifted the inactivation V1/2 by –30 mV to –57 mV and –66 637 
mV respectively (20, 23, 27, 31). The presence of these silent subunits accounts for the 638 
negative inactivation V1/2 of Kv2.1 observed in mouse urinary bladder smooth muscle cells 639 
(37), pyramidal neurones (11) and cerebral arterial myocytes (41), and may also be 640 
responsible for the negative inactivation V1/2 observed in RUSMC. Indeed, when we 641 
compared the transcriptional expression of the silent Kv subunits in RUSMC, we found that 642 
Kv9.3 message was ~4 fold higher than that of the other silent subunits tested and isolated 643 
RUSMC were immunopositive to anti-Kv9.3 antibodies.  644 
It is important to note that although there was no significant difference in the time constant of 645 
deactivation between the HEKKv2.1 and HEKKv2.2 cells currents, there was more variation in 646 
the deactivation time constants recorded from the HEKKv2.1 cells.  Whether this is caused by 647 
an up-regulation in silent Kv subunit expression in some of these stably transfected cells has 648 
not been determined, but is worthy of further investigation. 649 
Another possibility for the difference in inactivation V1/2 between the rabbit Kv2.1 and other 650 
homologues may due to the phosphorylation state of the channel. A number of studies have 651 
demonstrated that steady state inactivation of Kv2.1 channels is significantly shifted by up to 652 
35 mV in the negative direction by dephosphorylation (21, 22). Indeed the very negative 653 
inactivation V1/2 obtained in the native cells and the Kv2.1 channels expressed in HEK cells 654 
in the present study are consistent with the idea that RUSMC Kv2.1 channels are in a hypo-655 
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phosphorylated state. Whether this is a feature of rabbit Kv2.1 channels or specific to rabbit 656 
urethral smooth muscle cells is unknown. Given that the Kv2.1 protein identified with 657 
Western blotting was close to the predicted size, supports the idea that urethral Kv2 channels, 658 
when expressed in HEK cells at least, are unlikely to be highly phosphorylated. 659 
It is also important to note that we detected transcript for Kv2.2 in urethral smooth muscle 660 
and some membrane bound staining for Kv2.2 in isolated RUSMC. Therefore, we can not 661 
exclude the possibility that these channels, as homomers or heteromers with Kv2.1, may also 662 
contribute to the Kv current in RUSMC.  663 
 664 
Role of Kv2 current in the urethra. 665 
To assess the contribution of the Kv2 current to the electrical activity of the RUSMC, we 666 
examined the effects of ScTx on resting membrane potential (RMP) and on APs evoked by 667 
brief current injections, as shown in Figure 10. Given that little Kv current is activated at –60 668 
mV (see Figure 3D), it was not surprising that blockade of Kv2 channels had little effect on 669 
RMP and suggests that these channels contribute little to setting the RMP.  We were initially 670 
surprised to find that ScTx, even at a concentration of 300 nM (which should block the 671 
current by more than 50%), had little effect on the AP. Although Figure 10A suggests that 672 
the duration of the AP afterhyperpolarisation was decreased in the presence of ScTx, this 673 
effect was not found to be statistically significant.  However, when the activation kinetics of 674 
the transient BK current and the Kv2.1 current are compared, it is apparent that the Kv2.1 675 
current activates sufficiently slowly that it, in contrast to the transient BK current, is unlikely 676 
to contribute to the brief AP. However, when the BK current was inhibited with Pen A, 677 
application of ScTx further increased the duration the AP, suggesting that under these 678 
conditions at least, the Kv2 current contributes to the repolarisation phase of the AP. The 679 
prolongation of the AP after Kv2 blockade would presumably increase Ca2+ influx and 680 
enhance spontaneous contractions of the urethra. Indeed, when we examined ScTx on 681 
spontaneous contractions, we observed that it alone had little effect on the amplitude 682 
spontaneous contractions. However, when the BK channels were first blocked with Pen A, 683 
inhibition of Kv2 current increased the amplitude of the contractions approximately threefold.  684 
In summary, the results of this study suggest that the Kv current in RUSMC cells is likely to 685 
be carried through Kv2.1 channels and that inhibition of this current prolongs the AP and 686 
enhances contractile activity of the urethra, but only when the transient BK current is 687 
        
 
 
 23
inhibited. We have previously shown that noradrenaline can broaden the evoked AP by 688 
inhibiting the transient BK current (40). It is possible that part of this effect may also be 689 
mediated through regulation of Kv2 channels in these cells and future studies will examine if 690 
these currents are regulated by excitatory and inhibitory neurotransmitters in the urethra. 691 
 692 
 693 
 694 
 695 
 696 
697 
        
 
 
 24
ACKNOWLEDGEMENTS. 698 
 699 
The authors would like to acknowledge the National Institutes of Health (NIDDK Grant 700 
number R01 DK68565) for funding this study. B.K was in receipt of a Ph.D. studentship 701 
from the Council of Directors, Ireland. This work was also supported by a grant from Takeda 702 
Science Foundation (S.O.), Science Foundation Ireland and the Health Research Board. 703 
 704 
705 
        
 
 
 25
REFERENCES 706 
 707 
1. Albarwani S, Nemetz LT, Madden JA, Tobin AA, England SK, Pratt PF, and 708 
Rusch NJ. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity 709 
of the functional channels. J Physiol 551: 751–763, 2003 710 
 711 
2. Amberg GC, Santana LF. Kv2 channels oppose myogenic constriction of rat cerebral 712 
arteries. Am J Physiol Cell Physiol; 291(2):C348-56. 2006 713 
 714 
3. Amberg GC, Baker SA, Koh SD, Hatton WJ, Murray KJ, Horowitz B & Sanders KM. 715 
Characterisation of the A-type potassium current in mouse gastric antrum. J Physiol 544: 716 
417-428. 2002 717 
 718 
4. Archer SL, Souil E, Dinh-Xuan AT, Schremmer B, Mercier J C, El Yaagoubi A, Nguyen-719 
Huu L, Reeve HL, and Hampl V. Molecular identification of the role of voltage-gated K+ 720 
channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting 721 
membrane potential in rat pulmonary artery myocytes. J Clin Invest. 101(11): 2319–2330. 722 
1998. 723 
 724 
5. Brading AF. Spontaneous activity of lower urinary tract smooth muscles: correlation 725 
between ion channels and tissue function. J Physiol. 570 (Pt 1): 13-22. 2006 726 
 727 
6. Bradley JE, Anderson UA, Woolsey SM, Thornbury KD, McHale NG, Hollywood MA. 728 
Characterization of T-type calcium current and its contribution to electrical activity in rabbit 729 
urethra. American Journal of Physiology. Cell Physiol. 286(5): C1078-88. 2004 730 
 731 
7. Chen M, Kellett WF, Petkov GV. Voltage-gated K+ channels sensitive to stromatoxin-1 732 
regulate myogenic and neurogenic contractions of rat urinary bladder smooth muscle 733 
American Journal of Physiology - Regu Physiol. 299(1): R177-R184. 2010. 734 
 735 
8. Cole WC & Clement-Chomienne O. Properties, regulation and role of potassium 736 
channels in smooth muscle. In Advances in Organ Biology, vol. 8, ed. Barr L & Christ GJ, 737 
pp. 247–317. JAI Press, Stamford, Connecticut, USA. 2000 738 
 739 
9. Cotton, K.D, Hollywood, M.A., McHale, N.G.  & Thornbury, K.D. Ca2+-current and 740 
Ca2+-activated chloride current in isolated smooth muscle cells of the sheep urethra. Journal 741 
of Physiology.  505.1, 121-131, 1997. 742 
 743 
10. Escoubas P, Diochot S, Celerier ML, Nakajima T & Lazdunski M. Novel tarantula toxins 744 
for subtypes of voltage-dependent potassium channels in the Kv2 and Kv4 subfamilies. Mol 745 
Pharmacol 62, 48-57, 2002. 746 
 747 
11. Guan D, Tkatch T, Surmeier DJ, Armstrong WE & Foehring RC. Kv2 subunits underlie 748 
slowly inactivating potassium current in rat neocortical pyramidal neurons. J Physiol; 749 
581:941–60, 2007. 750 
12. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson 751 
GA, Rudy B, Sanguinetti MC, Stuhmer W & Wang X. International Union of Pharmacology. 752 
        
 
 
 26
LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. 753 
Pharmacol Rev 57:473–508, 2005 754 
 755 
13. Hamill O.P., Marty A., Neher E., Sakmann B. and Sigworth F.J. Improved patch-clamp 756 
techniques for high-resolution current recording from cells and cell-free membrane patches. 757 
Pflügers Arch.  391 (2): 85-100, 1981. 758 
 759 
14. Hart PJ, Overturf KE, Russell SN, Carl A, Hume JR, Sanders KM & Horowitz B. 760 
Cloning and expression of a Kv1.2 class delayed rectifier K+ channel from canine colonic 761 
smooth muscle. Proc Natl Acad Sci U S A 90, 9659–9663, 1993. 762 
 763 
15. Harvey AL (2001). Twenty years of dendrotoxins. Toxicon 39(1),15-26. Review. 764 
 765 
16. Hatton WJ, Mason HS, Carl A, Doherty P, Latten MJ, Kenyon JL, Sanders KM, and 766 
Horowitz B. Functional and molecular expression of a voltage-dependent K(+) channel 767 
(Kv1.1) in interstitial cells of Cajal. J Physiol 533: 315-327, 2001. 768 
 769 
17. Hollywood MA, McCloskey KD, McHale NG & Thornbury KD. Characterization of 770 
outward K+ currents in isolated smooth muscle cells from sheep urethra. Am J Physiol Cell 771 
Physiol. 279 (2): C420-8, 2000. 772 
 773 
18. Hollywood MA, Woolsey S, Walsh IK, Keane PF, McHale NG, Thornbury KD.  T- and 774 
L-type Ca2+ Currents in freshly dispersed smooth muscle cells from the human proximal 775 
urethra. J. Physiol.  550:753-64, 2003. 776 
 777 
19. Johnston J, Griffin SJ, Baker C, Skrzypiec A, Chernova T & Forsythe ID. Initial segment 778 
Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential 779 
firing in medial nucleus of the trapezoid body neurons. J Physiol.; 586: 3493–3509, 2008. 780 
 781 
20. Kramer JW, Post MA, Brown AM & Kirsch GE. Modulation of potassium channel gating 782 
by coexpression of Kv2.1 with regulatory Kv5.1 or Kv6.1 alpha-subunits. Am J Physiol 274, 783 
C1501–1510, 1998. 784 
 785 
21. Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE & 786 
Trimmer JS. Regulation of ion channel localization and phosphorylation by neuronal activity. 787 
Nat Neurosci  7: 711–718, 2004. 788 
 789 
22. Mohapatra DP & Trimmer JS. The Kv2.1 C terminus can autonomously transfer Kv2.1-790 
like phosphorylation-dependent localization, voltage-dependent gating, and muscarinic 791 
modulation to diverse Kv channels. J Neurosci; 26: 685–95, 2006 792 
 793 
23. Moreno-Domínguez A, Cidad P, Miguel-Velado E, López-López JR, Pérez-García MT. 794 
(2009) De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell 795 
excitability in a hypertensive mice strain. J Physiol. 587 (Pt 3):625-40.  2009 796 
 797 
24. Ohya S, Tanaka M, Watanable M, Imaizumi Y.  Diverse Expression of Delayed Rectifier 798 
K+ Channel Subtype Transcripts in Several Types of Smooth Muscles of the Rat.  Journal of 799 
Smooth Muscle Research, 36 (3). 101-115 (2000) 800 
 801 
        
 
 
 27
25. Ottschytsch N, Raes A, Van Hoorick D & Snyders DJ. Obligatory heterotetramerization 802 
of three previously uncharacterized Kv channel alpha-subunits identified in the human 803 
genome. Proc Natl Acad Sci USA 99, 7986–7991, 2002. 804 
 805 
26. Patel AJ, Lazdunski M & Honore E. Kv2.1/Kv9.3, a novel ATP-dependent delayed-806 
rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J. 16, 6615–807 
6625, 1997. 808 
 809 
27. Post MA, Kirsch GE & Brown AM. Kv2.1 and electrically silent Kv6.1 potassium 810 
channel subunits combine and express a novel current. FEBS Lett 399, 177–182, 1996. 811 
 812 
28. Rae J., Cooper K., Gates P. & Watsky M. Low access resistance perforated patch 813 
recordings using amphotericin B.  J. Neurosci. Methods.  37: 15-26, 1991. 814 
 815 
29. Robertson B, Owen D, Stow J, Butler C, and Newland C. Novel effects of dendrotoxin 816 
homologues on subtypes of mammalian Kv1 potassium channels expressed in Xenopus 817 
oocytes. FEBS Lett 383: 26-30, 1996. 818 
 819 
30. Salinas M, Duprat F, Heurteaux C, Hugnot JP & Lazdunski M. New modulatory a 820 
subunits for mammalian Shab K+ channels. J Biol Chem 272, 24371–24379, 1997. 821 
 822 
31. Sano Y, Mochizuki S, Miyake A, Kitada C, Inamura K, Yokoi H, Nozawa K, 823 
Matsushime H & Furuichi K (2002). Molecular cloning and characterization of Kv6.3, a 824 
novel modulatory subunit for voltage-gated K+ channel Kv2.1. FEBS Lett 512, 230–234 825 
 826 
32. Schmalz F, Kinsella J, Koh SD, Vogalis F, Schneider A, Flynn ER, Kenyon JL & 827 
Horowitz B. Molecular identification of a component of delayed rectifier current in 828 
gastrointestinal smooth muscles. Am J Physiol 274, G901–911, 1998. 829 
 830 
33. Sergeant GP, Hollywood MA, McCloskey KD, Thornbury K.D. & McHale NG. 831 
Specialised pacemaking cells in the rabbit urethra. J Physiol. 526 (2), 359-66, 2000. 832 
 833 
34. Teramoto N, Brading A.F. Activation by levcromakalim and metabolic inhibition of 834 
glibenclamide-sensitive K channels in smooth muscle cells of pig proximal urethra. Br. J. 835 
Pharmacol.  118:635–642, 1996. 836 
 837 
35. Teramoto N,  Brading A.F. The effects of nifedipine and other calcium antagonists on the 838 
glibenclamide-sensitive K+ currents in smooth muscle cells from pig urethra. Br. J. 839 
Pharmacol. 123:1601–1608, 1998. 840 
 841 
36. Teramoto N, Creed, K.E., Brading A.F.  Activity of glibenclamide-sensitive K+ channels 842 
under unstimulated conditions in smooth muscle cells of pig proximal urethra. Naunyn-843 
Schmiedeberg's Arch. Pharmacol.;356:418–424, 1997. 844 
 845 
37. Thorneloe KS & Nelson MT. Properties and molecular basis of the mouse urinary bladder 846 
voltage-gated K+ current. J Physiol 549, 65-74, 2003. 847 
 848 
38. Tobin AA, Joseph BK, Albarwani S, Al-Kindi HN, Madden JA, Nemetz LT, Rusch NJ, 849 
Rhee SW. Loss of cerebrovascular Shaker-type K+ channels: a shared vasodilator defect of 850 
        
 
 
 28
genetic and renal hypertensive rats. Am J Physiol – Heart Circ Physiol, 297(1): H293-H303, 851 
2009. 852 
 853 
39. Vega-Saenz de Miera EC. (2004). Modification of Kv2.1 K+ currents by the silent Kv10 854 
subunits. Brain Res Mol Brain Res. 123(1-2):91-103. 2004. 855 
 856 
40. Woolsey, S., Thornbury, KD., McHale, NG and Hollywood MA. Effects of 857 
noradrenaline on transient BK current in freshly dispersed smooth muscle cells from the 858 
rabbit urethra. J Physiol  543P  S154, 2002 859 
41. Zhong XZ, Abd-Elrahman KS, Liao CH, El-Yazbi AF, Walsh EJ, Walsh MP, Cole WC. 860 
Stromatoxin-sensitive, heteromultimeric Kv2.1/Kv9.3 channels contribute to myogenic 861 
control of cerebral arterial diameter. J Physiol. J Physiol 588, 4519-4537. 2010. 862 
 863 
42.  Zhu XR, Netzer R, Bohlke K, Liu Q & Pongs O. Structural and functional 864 
characterization of Kv6.2 a new g-subunit of voltage-gated potassium channel. Receptors 865 
Channels 6, 337–350, 1999. 866 
 867 
868 
        
 
 
 29
FIGURE LEGENDS 869 
 870 
Figure 1. Blockade of transient BK current in USMC unmasks a slowly 871 
activating outward current. Currents were evoked from -60 mV to +40 mV for 500 872 
ms and repolarised back to -60 mV. A: IbTx blocks BK current and unmasks a 873 
delayed rectifier current. B: Approximately 30% of outward current is insensitive to 874 
IbTx. C: Pen A also blocks the transient and sustained currents to unmask a Kv 875 
current. D: Summary data showing the effect of Pen A on peak outward current 876 
evoked by a step to +40 mV. E: Typical IV of the Kv currents. Note that large tail 877 
currents were elicited when this cell was repolarised back to –40 mV. F: Summary 878 
IV of Kv currents recorded in Ca2+ free and Pen A (n=18). 879 
 880 
Figure 2. RUSMC KV current is resistant to Kv1 selective toxins. Currents were 881 
evoked in all experiments from -80 mV to +40 mV for 500 ms. A: Effect of α-882 
dendrotoxin on the Kv current from USMCs in the presence of Pen A. B: Summary 883 
data from 3 cells in which α-dendrotoxin (filled bars) failed to inhibit the Kv current. 884 
C: Effect of κ-dendrotoxin on the Kv current from USMCs in the presence of Pen A. 885 
D: Summary data from 5 cells in which κ-dendrotoxin (filled bars) failed to inhibit the 886 
Kv current. E: The pan-Kv1 blocker margatoxin (filled bars), also failed to block the 887 
Kv current evoked by a step to +40 mV. F: Summary data from 3 cells. 888 
 889 
Figure 3. Rabbit USMC Kv current is sensitive to ScTx. A: Typical family of 890 
currents recorded in the absence of external Ca2+ and the presence of Pen A (100 891 
nM). B: Currents from same cell in the presence of ScTx (100 nM). C: Summary IV 892 
plots from 12 cells of peak outward current in the absence (open circles) and 893 
presence (filled circles) of ScTx (100 nM).  894 
 895 
Figure 4. Transcriptional and immunocytochemical detection of Kv2 subtypes 896 
in the rabbit urethra. A: Upper panel shows transcriptional detection of Kv2.1 897 
detected in control (brain) and strips of urethra (lower panel) from 4 animals. 898 
Expected amplicon size=196 bp. Lower panel shows Kv2.2 detection in the same 5 899 
tissues. Expected amplicon size= 149bp. No signal was detected in either non 900 
template control (NTC). B: Q-PCR determination of Kv2.1 and Kv2.2 transcriptional 901 
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detection obtained from urethra from 6 animals. The expression of Kv2 message 902 
(n=6, filled bars) was ~3 fold higher compared to Kv1.2, Kv1.3, Kv1.7, Kv4.2 or Kv4.3 903 
(n=3, open bars). C: Transmitted light and fluorescent images obtained from freshly 904 
dispersed RUSMC incubated with anti-Kv2.1 primary and secondary (Ci & Cii) 905 
antibodies, or with secondary antibody alone (Ciii & Civ). D: Transmitted light and 906 
fluorescent images obtained from freshly dispersed RUSMC incubated with anti-907 
Kv2.2 primary and secondary (Di & Dii) antibodies, or with secondary antibody alone 908 
(Diii & Div). The calibration bars represent 20 μm. 909 
 910 
Figure 5. Immunocytochemical detection of Kv2 subtypes in HEK cells. A: 911 
Transmitted light and fluorescent images obtained from HEK cells stably transfected 912 
with Kv2.1 and incubated with anti-Kv2.1 primary and secondary (Ai & Aii) 913 
antibodies, or with secondary antibody alone (Aiii & Aiv). B: Transmitted light and 914 
fluorescent images obtained from HEK cells stably transfected with Kv2.2 incubated 915 
with anti-Kv2.2 primary and secondary (Bi & Bii) antibodies, or with secondary 916 
antibody alone (Biii & Biv). The calibration bars represent 20 μm. C: Western blots 917 
from membrane fractions obtained from vector transfected HEK cells (left lane), HEK 918 
cells stably transfected with Kv2.1 (middle lane) and incubated with anti-Kv2.1 919 
primary antibody in the presence of excess antigen (right lane) D. Western blots 920 
from membrane fractions obtained from vector transfected HEK cells (left lane), HEK 921 
cells stably transfected with Kv2.2 (middle lane) and incubated with anti-Kv2.2 922 
primary antibody in the presence of excess antigen (right lane).  923 
 924 
Figure 6. Comparison of RUSMC ScTx-sensitive Kv current with currents from 925 
HEK cells stably transfected with Kv2.1 and Kv2.2 channels. A: A typical family of 926 
ScTx difference currents obtained by digitally subtracting the current in the presence 927 
of ScTx from the control currents. B: Mean activation data obtained from the ScTx-928 
sensitive difference currents from twelve RUSMC. Panels C and D show a typical 929 
family of Kv2.1 currents and the associated activation curve, respectively.  Panels E 930 
and F show typical Kv2.2 currents and the summary activation curve, respectively. 931 
The solid lines in Panels B, D & F show the Boltzmann fits of the mean data ± SEM.  932 
 933 
Figure 7. Evidence that RUSMC express silent Kv subunits. A: Time constant of 934 
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activation is plotted against voltage for native cells (open circles) and HEK cells 935 
expressing Kv2.1 (filled circles) and Kv2.2 (filled squares). B: Shows the deactivation 936 
time constant measured following a repolarising step to -40 mV from 30 mV in native 937 
cells (n=21) and HEK cells stably expressing Kv2.1 (n=10) and Kv2.2 (n=10). C. Q-938 
PCR data comparing the transcriptional expression of silent Kv subunits in the rabbit 939 
urethra. D. Transmitted light and fluorescent images obtained from freshly dispersed 940 
RUSMC and incubated with anti-Kv9.3 primary and secondary (Di & Dii) antibodies, 941 
or with secondary antibody alone (Diii &Div). 942 
 943 
Figure 8. Steady-state inactivation of the native Kv current is similar to Kv2.1, 944 
but not Kv2.2 channels stably expressed in HEK cells. Standard double pulse 945 
protocols shown in the inlay, were used to examine the steady-state voltage-946 
dependent inactivation of Kv currents in RUSMC (A), Kv2.1 (C) and Kv2.2 channels 947 
(E) stably-expressed in HEK cells. Summary inactivation curves for native Kv in 948 
RUSMC (B, n=9), Kv2.1 (D, n=13) and Kv2.2 channels (F, n=11) expressed in HEK 949 
cells. The solid lines represent the Boltzmann fit to the data and the mean 950 
inactivation V1/2 is shown. 951 
 952 
Figure 9. Comparison of ScTx effect on native RUSMC Kv current compared to 953 
Kv2.1 and Kv2.2 channels stably expressed in HEK cells. ScTx produced a 954 
concentration-dependent inhibition of native Kv currents (A), Kv2.1 (B), and Kv2.2 (C) 955 
currents stably expressed in HEK cells. When summary data were normalised and 956 
plotted against increasing concentrations of ScTx, there was little difference in the 957 
estimated IC50 for ScTx on the native current (B, n=7), Kv2.1 (D, n=5) or Kv2.2 (F, 958 
n=6) stably expressed in HEK cells. 959 
 960 
Figure 10. Kv2 blockade prolongs AP duration when BK channels are blocked. 961 
A: Current injection evoked a brief AP (black line) which was unaffected by ScTx 962 
application (300 nM, green line). B: APs evoked in control (black line), Pen A (red 963 
line) and ScTx plus Pen A (green line). C: Mean AP duration in control (white bar, 964 
23.7 ± 3 ms), 100 nM Pen A (red bar, 104.8 ± 17 ms) and ScTx plus pen A (green 965 
bar, 220.1 ± 61 ms, n=5). D: Average peak change in voltage for evoked AP in 966 
control (white bar, 65.3 ± 5 mV), pen A (100 nM, red bar, 87.8 ± 1 mV) and pen A 967 
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plus ScTx (300 nM, green bar, 90.8 ± 3 mV, n=5).  968 
 969 
Figure 11. Kv2 blockade enhances contractions when BK channels are 970 
blocked. 971 
A: Under control conditions, the urethra produced small amplitude contractions that 972 
were little affected by application of ScTx (100 nM). Summary data from seven 973 
experiments in which (B) contraction amplitude and (C) contraction frequency were 974 
compared before (open bars) and during ScTx (filled bars). D: Application of Pen A 975 
itself increased contraction frequency and amplitude and ScTx further enhanced this 976 
effect. Summary data from seven experiments in which (E) contraction amplitude 977 
and (F) contraction frequency were compared in the absence of any drugs (open 978 
bars), after Pen A application (gray bars) and during Pen A and ScTx application 979 
(black bars). 980 
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